EGFR c.2380C>T ;(p.P794S)

Variant ID: 7-55249082-C-T

NM_005228.3(EGFR):c.2380C>T;(p.P794S)

This variant was identified in 10 publications

View GRCh38 version.




Publications:


EGFR exon 19 deletion switch and development of p.L792Q mutation as a new resistance mechanism to osimertinib: a case report and literature review.

Translational Cancer Research
Pisapia, Pasquale P; Rocco, Danilo D; Pepe, Francesco F; De Luca, Caterina C; Battiloro, Ciro C; Smeraglio, Riccardo R; Cieri, Miriam M; Bellevicine, Claudio C; Troncone, Giancarlo G; Malapelle, Umberto U
Publication Date: 2019-01

Variant appearance in text: EGFR: P794S
PubMed Link: 35117065
Variant Present in the following documents:
  • Main text
  • tcr-08-S1-S64.pdf
View BVdb publication page



Liquid Biopsy in Gastric Cancer: Analysis of Somatic Cancer Tissue Mutations in Plasma Cell-Free DNA for Predicting Disease State and Patient Survival.

Clinical And Translational Gastroenterology
Varkalaite, Greta G; Forster, Michael M; Franke, Andre A; Kupcinskas, Juozas J; Skieceviciene, Jurgita J
Publication Date: 2021-09-24

Variant appearance in text: EGFR: 2380C>T; Pro794Ser
PubMed Link: 34644276
Variant Present in the following documents:
  • ct9-12-e00403-s006.pdf
View BVdb publication page



Acquired resistance to third-generation EGFR-TKIs and emerging next-generation EGFR inhibitors.

Innovation (Cambridge (Mass.))
Du, Xiaojing X; Yang, Biwei B; An, Quanlin Q; Assaraf, Yehuda G YG; Cao, Xin X; Xia, Jinglin J
Publication Date: 2021-05-28

Variant appearance in text: EGFR: P794S
PubMed Link: 34557754
Variant Present in the following documents:
  • Main text
View BVdb publication page



Acquired resistance to third-generation EGFR-TKIs and emerging next-generation EGFR inhibitors.

Innovation (New York, N.Y.)
Du, Xiaojing X; Yang, Biwei B; An, Quanlin Q; Assaraf, Yehuda G YG; Cao, Xin X; Xia, Jinglin J
Publication Date: 2021-05-28

Variant appearance in text: EGFR: P794S
PubMed Link: 34557754
Variant Present in the following documents:
  • Main text
View BVdb publication page



NGS-Based ctDNA Profiling After the Resistance of Second-Line Osimertinib for Patient with EGFR-Mutated Pulmonary Adenocarcinoma.

Oncotargets And Therapy
Li, Dan D; Yang, DaFu D; Cui, SaiQiong S; Pan, Evenki E; Yang, Peng P; Dai, ZhaoXia Z
Publication Date: 2021

Variant appearance in text: EGFR: P794S
PubMed Link: 34321891
Variant Present in the following documents:
  • Main text
  • ott-14-4261.pdf
View BVdb publication page



PD-L1 targeting and subclonal immune escape mediated by PD-L1 mutations in metastatic colorectal cancer.

Journal For Immunotherapy Of Cancer
Stein, Alexander A; Simnica, Donjete D; Schultheiß, Christoph C; Scholz, Rebekka R; Tintelnot, Joseph J; Gökkurt, Eray E; von Wenserski, Lisa L; Willscher, Edith E; Paschold, Lisa L; Sauer, Markus M; Lorenzen, Sylvie S; Riera-Knorrenschild, Jorge J; Depenbusch, Reinhard R; Ettrich, Thomas J TJ; Dörfel, Steffen S; Al-Batran, Salah-Eddin SE; Karthaus, Meinolf M; Pelzer, Uwe U; Waberer, Lisa L; Hinke, Axel A; Bauer, Marcus M; Massa, Chiara C; Seliger, Barbara B; Wickenhauser, Claudia C; Bokemeyer, Carsten C; Hegewisch-Becker, Susanna S; Binder, Mascha M
Publication Date: 2021-07

Variant appearance in text: EGFR: 2380C>T; Pro794Ser
PubMed Link: 34315821
Variant Present in the following documents:
  • jitc-2021-002844supp002.xlsx, sheet 1
View BVdb publication page



Acquired rare recurrent EGFR mutations as mechanisms of resistance to Osimertinib in lung cancer and in silico structural modelling.

American Journal Of Cancer Research
Lin, Lin L; Lu, Qiang Q; Cao, Ran R; Ou, Qiuxiang Q; Ma, Yutong Y; Bao, Hua H; Wu, Xue X; Shao, Yang Y; Wang, Zhaoxia Z; Shen, Bo B
Publication Date: 2020

Variant appearance in text: EGFR: P794S
PubMed Link: 33294282
Variant Present in the following documents:
  • Main text
View BVdb publication page



Mutations of the MAPK/TSC/mTOR pathway characterize periventricular glioblastoma with epithelioid SEGA-like morphology-morphological and therapeutic implications.

Oncotarget
Georgescu, Maria-Magdalena MM; Li, Yan Y; Islam, Mohammad Zahidul MZ; Notarianni, Christina C; Sun, Hai H; Olar, Adriana A; Fuller, Gregory N GN
Publication Date: 2019-06-18

Variant appearance in text: EGFR: 2380C>T
PubMed Link: 31258848
Variant Present in the following documents:
  • oncotarget-10-4038-s001.pdf
View BVdb publication page



Finding driver mutations in cancer: Elucidating the role of background mutational processes.

Plos Computational Biology
Brown, Anna-Leigh AL; Li, Minghui M; Goncearenco, Alexander A; Panchenko, Anna R AR
Publication Date: 2019-04

Variant appearance in text: EGFR: P794S
PubMed Link: 31034466
Variant Present in the following documents:
  • pcbi.1006981.s010.xlsx, sheet 1
View BVdb publication page



Formalin fixation increases deamination mutation signature but should not lead to false positive mutations in clinical practice.

Plos One
Prentice, Leah M LM; Miller, Ruth R RR; Knaggs, Jeff J; Mazloomian, Alborz A; Aguirre Hernandez, Rosalia R; Franchini, Patrick P; Parsa, Kourosh K; Tessier-Cloutier, Basile B; Lapuk, Anna A; Huntsman, David D; Schaeffer, David F DF; Sheffield, Brandon S BS
Publication Date: 2018

Variant appearance in text: EGFR: P794S
PubMed Link: 29698444
Variant Present in the following documents:
  • pone.0196434.s001.xlsx, sheet 3
View BVdb publication page



Cis-oriented solvent-front EGFR G796S mutation in tissue and ctDNA in a patient progressing on osimertinib: a case report and review of the literature.

Lung Cancer (Auckland, N.Z.)
Klempner, Samuel J SJ; Mehta, Pareen P; Schrock, Alexa B AB; Ali, Siraj M SM; Ou, Sai-Hong Ignatius SI
Publication Date: 2017

Variant appearance in text: EGFR: P794S
PubMed Link: 29255376
Variant Present in the following documents:
  • Main text
  • lctt-8-241.pdf
View BVdb publication page